Literature DB >> 11805383

Intensive care unit management of the critically ill patient with fluid overload after open heart surgery.

R Bellomo1, J Raman, C Ronco.   

Abstract

Fluid overload is common before, during and after cardiac surgery. The fluid associated with cardiopulmonary bypass (CPB) and cardioplegia is a particularly important source of such fluid overload. In addition, renal dysfunction, which is common in these patients, participates in the pathogenesis of a positive sodium and water balance. Such fluid overload is physiologically undesirable and participates in the pathogenesis of several clinically important complications. Fluid overload can be partly prevented with the use of diuretics. However, in many patients, diuretics do not achieve sufficient sodium and water diuresis. In these patients, the application of hemofiltration (HF) during CPB and also immediately after CPB is an effective and safe approach to the maintenance of fluid homeostasis. If acute renal failure occurs, early intervention with HF may even improve survival. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11805383     DOI: 10.1159/000047400

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  12 in total

Review 1.  Current and future role of ultrafiltration in CRS.

Authors:  Claudio Ronco; Pierpaolo Giomarelli
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

2.  The correlation of fluid balance changes during cardiopulmonary bypass to mortality in pediatric and congenital heart surgery patients.

Authors:  Gary Grist; Carrie Whittaker; Kellie Merrigan; Jason Fenton; Elizabeth Worrall; James O'Brien; Gary Lofland
Journal:  J Extra Corpor Technol       Date:  2011-12

3.  The impact of fluid balance on diagnosis, staging and prediction of mortality in critically ill patients with acute kidney injury.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Narat Srivali; Patompong Ungprasert; Wonngarm Kittanamongkolchai; Kianoush Kashani
Journal:  J Nephrol       Date:  2015-05-27       Impact factor: 3.902

4.  Draining Fluids through a Peritoneal Catheter in Newborns after Cardiac Surgery Helps to Control Fluid Balance.

Authors:  Elisa Ruano Cea; Philippe Jouvet; Suzanne Vobecky; Aicha Merouani
Journal:  Case Rep Med       Date:  2010-03-30

5.  Lower-Dose, Intravenous Chlorothiazide Is an Effective Adjunct Diuretic to Furosemide Following Pediatric Cardiac Surgery.

Authors:  Ryan J Carpenter; Shaghig Kouyoumjian; David Y Moromisato; Phuong Lieu; Rambod Amirnovin
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

6.  High volumes of intravenous fluid during cardiac surgery are associated with increased mortality.

Authors:  A Pradeep; S Rajagopalam; H K Kolli; N Patel; R Venuto; J Lohr; N D Nader
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

7.  Recruitment of sublingual microcirculation using handheld incident dark field imaging as a routine measurement tool during the postoperative de-escalation phase-a pilot study in post ICU cardiac surgery patients.

Authors:  Zühre Uz; Can Ince; Philippe Guerci; Yasin Ince; Renata P Araujo; Bulent Ergin; Matthias P Hilty; Thomas M van Gulik; Bas A de Mol
Journal:  Perioper Med (Lond)       Date:  2018-08-09

8.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05

9.  Acute Systemic Inflammation is Unlikely to Affect Adiponectin and Leptin Synthesis in Humans.

Authors:  Mattias Ekström; Stefan Söderberg; Per Tornvall
Journal:  Front Cardiovasc Med       Date:  2015-03-05

10.  Ultrasonographic caval indices do not significantly contribute to predicting fluid responsiveness immediately after coronary artery bypass grafting when compared to passive leg raising.

Authors:  Dorota Sobczyk; Krzysztof Nycz; Pawel Andruszkiewicz; Karol Wierzbicki; Maciej Stapor
Journal:  Cardiovasc Ultrasound       Date:  2016-06-08       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.